HUMA
Humacyte, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.60
+0.76%Leverage
- Debt / equity
- 2.12x
- Net debt / equity
- -0.44x
- Debt / assets
- 0.48x
- Debt / EBITDA
- -0.83x
- Net debt / EBITDA
- 0.17x
Liquidity & coverage
- Current ratio
- 6.21x
- Quick ratio
- 5.74x
- Cash ratio
- 5.35x
- Interest coverage
- -10.80x
- EBITDA / interest
- -7.74x
- Working capital
- $77.8M
Cash & dividend
- FCF / debt
- -1.47x
- Cash flow / debt
- -1.47x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026